Richard Pzena's Hancock Classic Value Portfolio Shows Significant Shifts in Q1 2026
Richard Pzena's portfolio, valued at approximately $30.7 billion as of March 31, 2026, saw notable changes in holdings, with significant increases in CTSH, SWKS, and HUM, alongside decreases in several other stocks.
As of March 31, 2026, Richard Pzena's Hancock Classic Value portfolio held a total value of approximately $30.7 billion, with a focus on sectors including Healthcare, Technology, and Financial Services.
Among the top holdings, several stocks showed significant changes in share count during the quarter:
Cognizant Technology Solutions (CTSH) saw a substantial increase of 14.94% in its share count, indicating renewed confidence in the Technology sector.
Tyson Foods (TSN) experienced a notable 12.05% increase in shares, reflecting a strengthening position in the Consumer Defensive space.
Skyworks Solutions (SWKS) added shares with a 27.57% increase, highlighting a significant stake in the Technology sector.
Humana (HUM) showed a remarkable 34.35% jump in shares, making it one of the most pronounced additions to the portfolio.
Conversely, several positions were reduced:
Magna International (MGA) saw a 13% decrease in shares, impacting its portfolio allocation.
Baxter International (BAX) experienced an 7.88% reduction in holdings.
Bristol Myers Squibb (BMY) and CVS Health (CVS) both saw decreases of 4.72% and 11.61%, respectively.
Citigroup (C) faced a significant 22.98% reduction in its stake.
Capital One (COF) also saw an 8.78% decrease in its position.
For a complete view of investor activity, visit the investor profile at Richard Pzena on Insiderset. Detailed analysis of each stock can be found at MGA, CTSH, TSN, BAX, BMY, CVS, HUM, C, and SWKS.